Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5366-5373

  Velders, M P ^a   Weijzen, S ^a   Eiben, G L ^a   Elmishad, A G ^a   Kloetzel, P M ^a   Higgins, T ^a   Ciccarelli, R B ^a   Evans, M ^a   Man, S ^a   Smith, L ^a   Kast, W M ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CANCER PREVENTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE GUN; HELPER CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECOMBINANT DNA TECHNOLOGY; UTERINE CERVIX CARCINOMA; VACCINATION; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0035340260     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5366     Document Type: Article

References (52)

1. Genital human papillomavirus infection in female university students as determined by a PCR-based method
2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
3. Epidemiology of genital human papillomavirus infection
4. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer
5. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment
6. Active immunization against cancer cells: Impediments and advances
7. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge
8. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens
9. Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus
10. Multivalent minigene vaccines against infectious disease
11. Multi-epitope DNA vaccines
12. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
13. Association of human papillomavirus types 16 and 18 E6 proteins with p53
14. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides
15. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins
16. Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2
17. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
18. A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome
19. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope
20. + cytotoxic T cells: Implications for vaccine design
21. DNA immunization with minigenes: Low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination
22. Utilization of MHC class I transgeneic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes
23. + cytotoxic T lymphocytes: A novel approach to vaccine design
24. Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors
25. Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors
26. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA- A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E
27. Heterologous protection against influenza by injection of DNA encoding a viral protein
28. DNA vaccines
29. DNA vaccines
30. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
31. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A
32. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors
33. Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: Implications for cervical cancer immunotherapy
34. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
35. Mapping the major human T helper epitopes of tetanus toxin: The emerging picture
36. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide
37. A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes
38. + T cells after gene gun immunization
39. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein
40. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: Long-term protection and effect of revaccination
41. Costimulation provided by DNA immunization enhances antitumor immunity
42. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein
43. Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes
44. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences
45. The cleavage preference of the proteasome governs the yield of antigenic peptides
46. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein
47. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site
48. Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase 1
49. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7
50. Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: Clinical evaluation of a phase I-II trial
51. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive
52. Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein